Illumina Inc (NASDAQ: ILMN) is a life sciences instrumentation company that develops and sells systems for DNA sequencing and array-based genomic analysis. The filing excerpts provided do not contain sufficient detail to describe Illumina's revenue model, segment breakdown, customer base, geographic mix, competitive position, or financial metrics with source-grounded specificity. All such details are omitted per source-grounding rules. The 10-K was filed on 2026-02-12 under accession number 0001110803-26-000024 for the fiscal year ended in that period.

Source: SEC 10-K, filed 2026-02-12

Industry: Laboratory Analytical Instruments Peers: Agilent Technologies Inc Avantor Inc Danaher Corp Revvity Inc IQVIA Holdings Inc Mettler-toledo International Inc Thermo Fisher Scientific Inc West Pharmaceutical Services Inc Waters Corp